New Lancet Commission calls for urgent action to tackle Europe’s rising liver disease burden
New Lancet Commission calls for urgent action to tackle Europe's rising liver disease burden Every day in Europe, nearly 780 people die from cirrhosis or liver cancer — conditions that are largely…
EASL General Assembly 2026
The EASL General Assembly will take place on Friday, 29 May 2026, from 18:45 to 20:00 during EASL Congress 2026 in Barcelona. The meeting will be held in person in the Mondelli…
MICROB-PREDICT Consensus Survey for Hepatology Experts
We invite you to complete this short Consensus Survey in preparation for the MICROB-PREDICT Consensus Conference on Wednesday, 27 May 2026, during EASL Congress in Barcelona, Spain. Scope: Microbiome-based mechanisms and biomarkers for improved patient…
A tribute to Dr Ahmed Elsharkawy
The EASL community is deeply saddened by the loss of Dr Ahmed Elsharkawy, consultant transplant hepatologist, researcher, educator, and valued member of the EASL Governing Board. Ahmed served on the EASL Governing…
Press release: Alcohol abstinence can lead to regression of existing liver-related complications
Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in cases of advanced alcohol-related cirrhosis. This is shown by an international multicenter study led by…
New A-TANGO Score for better patient stratification Copy
We’re proud to share a major milestone for the A-TANGO Consortium: the latest publication is now available in the Journal of Hepatology: Highlights of this important publication: This study in global cohorts…
EASL Urges Support for WHO Resolution – “Steatotic Liver Disease – A Missing Piece in the Global Noncommunicable Disease Response”
Geneva, 18 February 2026 – The European Association for the Study of the Liver (EASL) has called on WHO Member States to support a landmark World Health Organization (WHO) draft resolution, “Steatotic…